Cogstate Limited
Cogstate Limited (COGZF) Stock Competitors & Peer Comparison
See (COGZF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| COGZF | $1.55 | +0.00% | 265.9M | 25.83 | $0.06 | +0.84% |
| PMCUF | $94.03 | -2.15% | 9.8B | 60.28 | $1.56 | +0.45% |
| MTHRY | $5.21 | +4.41% | 6.9B | 24.29 | $0.21 | +0.97% |
| MTHRF | $9.90 | -13.31% | 6.7B | 23.02 | $0.43 | +1.40% |
| PANHF | $1.55 | -12.22% | 3.3B | 154.50 | $0.01 | N/A |
| PIAHY | $4.40 | +0.00% | 2.4B | 146.67 | $0.03 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +0.17% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $24.20 | +0.00% | 850.6M | 44.00 | $0.55 | +1.73% |
| RSLBF | $23.00 | +0.00% | 822.2M | 32.39 | $0.71 | +1.37% |
Stock Comparison
COGZF vs PMCUF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PMCUF has a market cap of 9.8B. Regarding current trading prices, COGZF is priced at $1.55, while PMCUF trades at $94.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PMCUF's P/E ratio is 60.28. In terms of profitability, COGZF's ROE is +0.27%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, COGZF is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check PMCUF's competition here
COGZF vs MTHRY Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MTHRY has a market cap of 6.9B. Regarding current trading prices, COGZF is priced at $1.55, while MTHRY trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MTHRY's P/E ratio is 24.29. In terms of profitability, COGZF's ROE is +0.27%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, COGZF is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check MTHRY's competition here
COGZF vs MTHRF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MTHRF has a market cap of 6.7B. Regarding current trading prices, COGZF is priced at $1.55, while MTHRF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MTHRF's P/E ratio is 23.02. In terms of profitability, COGZF's ROE is +0.27%, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, COGZF and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
COGZF vs PANHF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PANHF has a market cap of 3.3B. Regarding current trading prices, COGZF is priced at $1.55, while PANHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PANHF's P/E ratio is 154.50. In terms of profitability, COGZF's ROE is +0.27%, compared to PANHF's ROE of +0.02%. Regarding short-term risk, COGZF and PANHF have similar daily volatility (0.00).Check PANHF's competition here
COGZF vs PIAHY Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PIAHY has a market cap of 2.4B. Regarding current trading prices, COGZF is priced at $1.55, while PIAHY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PIAHY's P/E ratio is 146.67. In terms of profitability, COGZF's ROE is +0.27%, compared to PIAHY's ROE of +0.02%. Regarding short-term risk, COGZF is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check PIAHY's competition here
COGZF vs CMPVF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, COGZF is priced at $1.55, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, COGZF's ROE is +0.27%, compared to CMPVF's ROE of +0.03%. Regarding short-term risk, COGZF is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CMPVF's competition here
COGZF vs CMPUY Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, COGZF is priced at $1.55, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, COGZF's ROE is +0.27%, compared to CMPUY's ROE of +0.02%. Regarding short-term risk, COGZF and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
COGZF vs CRWRF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CRWRF has a market cap of 850.6M. Regarding current trading prices, COGZF is priced at $1.55, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, COGZF's ROE is +0.27%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, COGZF is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CRWRF's competition here
COGZF vs RSLBF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RSLBF has a market cap of 822.2M. Regarding current trading prices, COGZF is priced at $1.55, while RSLBF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RSLBF's P/E ratio is 32.39. In terms of profitability, COGZF's ROE is +0.27%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, COGZF and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
COGZF vs SMSZF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, COGZF is priced at $1.55, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, COGZF's ROE is +0.27%, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, COGZF is less volatile compared to SMSZF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check SMSZF's competition here
COGZF vs VHIBF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, VHIBF has a market cap of 357.3M. Regarding current trading prices, COGZF is priced at $1.55, while VHIBF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas VHIBF's P/E ratio is 188.67. In terms of profitability, COGZF's ROE is +0.27%, compared to VHIBF's ROE of +0.01%. Regarding short-term risk, COGZF is less volatile compared to VHIBF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check VHIBF's competition here
COGZF vs SMDCF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, COGZF is priced at $1.55, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, COGZF's ROE is +0.27%, compared to SMDCF's ROE of N/A. Regarding short-term risk, COGZF and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
COGZF vs DLHTF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, COGZF is priced at $1.55, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, COGZF's ROE is +0.27%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, COGZF and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
COGZF vs KSIOF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, KSIOF has a market cap of 249M. Regarding current trading prices, COGZF is priced at $1.55, while KSIOF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas KSIOF's P/E ratio is -260.00. In terms of profitability, COGZF's ROE is +0.27%, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, COGZF is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check KSIOF's competition here
COGZF vs VPAHF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, COGZF is priced at $1.55, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, COGZF's ROE is +0.27%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, COGZF and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
COGZF vs ACMLF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ACMLF has a market cap of 157M. Regarding current trading prices, COGZF is priced at $1.55, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, COGZF's ROE is +0.27%, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, COGZF is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check ACMLF's competition here
COGZF vs SUSRF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, COGZF is priced at $1.55, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, COGZF's ROE is +0.27%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, COGZF is less volatile compared to SUSRF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check SUSRF's competition here
COGZF vs ONVVF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, COGZF is priced at $1.55, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, COGZF's ROE is +0.27%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, COGZF is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check ONVVF's competition here
COGZF vs CSAMF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, COGZF is priced at $1.55, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, COGZF's ROE is +0.27%, compared to CSAMF's ROE of -1.12%. Regarding short-term risk, COGZF and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
COGZF vs HITC Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, COGZF is priced at $1.55, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HITC's P/E ratio is -14.75. In terms of profitability, COGZF's ROE is +0.27%, compared to HITC's ROE of -0.78%. Regarding short-term risk, COGZF is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check HITC's competition here
COGZF vs MDPEF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, COGZF is priced at $1.55, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to MDPEF's ROE of N/A. Regarding short-term risk, COGZF and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
COGZF vs TREIF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, COGZF is priced at $1.55, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas TREIF's P/E ratio is -3.46. In terms of profitability, COGZF's ROE is +0.27%, compared to TREIF's ROE of -3.04%. Regarding short-term risk, COGZF is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check TREIF's competition here
COGZF vs EMOR Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, COGZF is priced at $1.55, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EMOR's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to EMOR's ROE of +0.02%. Regarding short-term risk, COGZF is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check EMOR's competition here
COGZF vs VASO Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, VASO has a market cap of 29M. Regarding current trading prices, COGZF is priced at $1.55, while VASO trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas VASO's P/E ratio is 8.25. In terms of profitability, COGZF's ROE is +0.27%, compared to VASO's ROE of +0.09%. Regarding short-term risk, COGZF and VASO have similar daily volatility (0.00).Check VASO's competition here
COGZF vs RTNXF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, COGZF is priced at $1.55, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, COGZF's ROE is +0.27%, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, COGZF is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check RTNXF's competition here
COGZF vs DGNOF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, DGNOF has a market cap of 21.8M. Regarding current trading prices, COGZF is priced at $1.55, while DGNOF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas DGNOF's P/E ratio is -5.35. In terms of profitability, COGZF's ROE is +0.27%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, COGZF is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check DGNOF's competition here
COGZF vs HDSLF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, COGZF is priced at $1.55, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, COGZF's ROE is +0.27%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, COGZF is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check HDSLF's competition here
COGZF vs THKKF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, COGZF is priced at $1.55, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas THKKF's P/E ratio is -1.51. In terms of profitability, COGZF's ROE is +0.27%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, COGZF and THKKF have similar daily volatility (0.00).Check THKKF's competition here
COGZF vs CRVW Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CRVW has a market cap of 17M. Regarding current trading prices, COGZF is priced at $1.55, while CRVW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CRVW's P/E ratio is -2.91. In terms of profitability, COGZF's ROE is +0.27%, compared to CRVW's ROE of +0.12%. Regarding short-term risk, COGZF and CRVW have similar daily volatility (0.00).Check CRVW's competition here
COGZF vs MNNDF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, COGZF is priced at $1.55, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, COGZF's ROE is +0.27%, compared to MNNDF's ROE of N/A. Regarding short-term risk, COGZF is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check MNNDF's competition here
COGZF vs WLSS Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, WLSS has a market cap of 12.7M. Regarding current trading prices, COGZF is priced at $1.55, while WLSS trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas WLSS's P/E ratio is -460.00. In terms of profitability, COGZF's ROE is +0.27%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, COGZF is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check WLSS's competition here
COGZF vs BRGX Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, BRGX has a market cap of 12.3M. Regarding current trading prices, COGZF is priced at $1.55, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas BRGX's P/E ratio is -1.27. In terms of profitability, COGZF's ROE is +0.27%, compared to BRGX's ROE of +5.32%. Regarding short-term risk, COGZF is less volatile compared to BRGX. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check BRGX's competition here
COGZF vs PBSV Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PBSV has a market cap of 11M. Regarding current trading prices, COGZF is priced at $1.55, while PBSV trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PBSV's P/E ratio is -48.00. In terms of profitability, COGZF's ROE is +0.27%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, COGZF and PBSV have similar daily volatility (0.00).Check PBSV's competition here
COGZF vs CMHSF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CMHSF has a market cap of 9.8M. Regarding current trading prices, COGZF is priced at $1.55, while CMHSF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CMHSF's P/E ratio is -3.63. In terms of profitability, COGZF's ROE is +0.27%, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, COGZF is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CMHSF's competition here
COGZF vs CDXFF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, COGZF is priced at $1.55, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, COGZF's ROE is +0.27%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, COGZF and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
COGZF vs UDOCF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, UDOCF has a market cap of 8.7M. Regarding current trading prices, COGZF is priced at $1.55, while UDOCF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas UDOCF's P/E ratio is -2.51. In terms of profitability, COGZF's ROE is +0.27%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, COGZF is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check UDOCF's competition here
COGZF vs HBCNF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, COGZF is priced at $1.55, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, COGZF's ROE is +0.27%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, COGZF is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check HBCNF's competition here
COGZF vs SPLTF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, COGZF is priced at $1.55, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, COGZF's ROE is +0.27%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, COGZF is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check SPLTF's competition here
COGZF vs CMPD Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CMPD has a market cap of 7.9M. Regarding current trading prices, COGZF is priced at $1.55, while CMPD trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CMPD's P/E ratio is -14.93. In terms of profitability, COGZF's ROE is +0.27%, compared to CMPD's ROE of -0.04%. Regarding short-term risk, COGZF is less volatile compared to CMPD. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CMPD's competition here
COGZF vs VYND Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, COGZF is priced at $1.55, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas VYND's P/E ratio is -43.00. In terms of profitability, COGZF's ROE is +0.27%, compared to VYND's ROE of +0.92%. Regarding short-term risk, COGZF and VYND have similar daily volatility (0.00).Check VYND's competition here
COGZF vs CRBKF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, COGZF is priced at $1.55, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, COGZF's ROE is +0.27%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, COGZF and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
COGZF vs DOCRF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, COGZF is priced at $1.55, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, COGZF's ROE is +0.27%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, COGZF and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
COGZF vs IQAIF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, COGZF is priced at $1.55, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas IQAIF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, COGZF is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check IQAIF's competition here
COGZF vs AIMLF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, AIMLF has a market cap of 4.4M. Regarding current trading prices, COGZF is priced at $1.55, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas AIMLF's P/E ratio is -1.29. In terms of profitability, COGZF's ROE is +0.27%, compared to AIMLF's ROE of -3.31%. Regarding short-term risk, COGZF is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check AIMLF's competition here
COGZF vs CBDS Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, COGZF is priced at $1.55, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CBDS's P/E ratio is -1.49. In terms of profitability, COGZF's ROE is +0.27%, compared to CBDS's ROE of +1.18%. Regarding short-term risk, COGZF is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CBDS's competition here
COGZF vs RQHTF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, COGZF is priced at $1.55, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, COGZF's ROE is +0.27%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, COGZF and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
COGZF vs CSOC Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CSOC has a market cap of 2.5M. Regarding current trading prices, COGZF is priced at $1.55, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CSOC's P/E ratio is 0.30. In terms of profitability, COGZF's ROE is +0.27%, compared to CSOC's ROE of -0.99%. Regarding short-term risk, COGZF is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CSOC's competition here
COGZF vs RYAHF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, COGZF is priced at $1.55, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, COGZF's ROE is +0.27%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, COGZF and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
COGZF vs RSLT Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RSLT has a market cap of 2.2M. Regarding current trading prices, COGZF is priced at $1.55, while RSLT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RSLT's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to RSLT's ROE of N/A. Regarding short-term risk, COGZF is less volatile compared to RSLT. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check RSLT's competition here
COGZF vs EBYH Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EBYH has a market cap of 2M. Regarding current trading prices, COGZF is priced at $1.55, while EBYH trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EBYH's P/E ratio is -5.68. In terms of profitability, COGZF's ROE is +0.27%, compared to EBYH's ROE of +0.14%. Regarding short-term risk, COGZF is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check EBYH's competition here
COGZF vs MDBIF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, COGZF is priced at $1.55, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, COGZF's ROE is +0.27%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, COGZF is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check MDBIF's competition here
COGZF vs MITI Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MITI has a market cap of 1.2M. Regarding current trading prices, COGZF is priced at $1.55, while MITI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MITI's P/E ratio is -0.16. In terms of profitability, COGZF's ROE is +0.27%, compared to MITI's ROE of +0.17%. Regarding short-term risk, COGZF and MITI have similar daily volatility (0.00).Check MITI's competition here
COGZF vs EKGGF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, COGZF is priced at $1.55, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EKGGF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, COGZF is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check EKGGF's competition here
COGZF vs PPJE Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PPJE has a market cap of 890.5K. Regarding current trading prices, COGZF is priced at $1.55, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PPJE's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, COGZF and PPJE have similar daily volatility (0.00).Check PPJE's competition here
COGZF vs NDATF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, NDATF has a market cap of 826.5K. Regarding current trading prices, COGZF is priced at $1.55, while NDATF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas NDATF's P/E ratio is -2.00. In terms of profitability, COGZF's ROE is +0.27%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, COGZF is less volatile compared to NDATF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check NDATF's competition here
COGZF vs EVAHF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EVAHF has a market cap of 662.2K. Regarding current trading prices, COGZF is priced at $1.55, while EVAHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EVAHF's P/E ratio is -0.27. In terms of profitability, COGZF's ROE is +0.27%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, COGZF and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
COGZF vs DSOL Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, DSOL has a market cap of 622.2K. Regarding current trading prices, COGZF is priced at $1.55, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas DSOL's P/E ratio is -0.02. In terms of profitability, COGZF's ROE is +0.27%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, COGZF and DSOL have similar daily volatility (0.00).Check DSOL's competition here
COGZF vs MDNWF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, COGZF is priced at $1.55, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, COGZF's ROE is +0.27%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, COGZF is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check MDNWF's competition here
COGZF vs DTRK Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, DTRK has a market cap of 511.2K. Regarding current trading prices, COGZF is priced at $1.55, while DTRK trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas DTRK's P/E ratio is -4.44. In terms of profitability, COGZF's ROE is +0.27%, compared to DTRK's ROE of +3.54%. Regarding short-term risk, COGZF is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check DTRK's competition here
COGZF vs USPS Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, USPS has a market cap of 455.1K. Regarding current trading prices, COGZF is priced at $1.55, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas USPS's P/E ratio is -2.87. In terms of profitability, COGZF's ROE is +0.27%, compared to USPS's ROE of +0.62%. Regarding short-term risk, COGZF is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check USPS's competition here
COGZF vs CTVEF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, COGZF is priced at $1.55, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, COGZF's ROE is +0.27%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, COGZF is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CTVEF's competition here
COGZF vs MDRM Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MDRM has a market cap of 382.6K. Regarding current trading prices, COGZF is priced at $1.55, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MDRM's P/E ratio is -0.30. In terms of profitability, COGZF's ROE is +0.27%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, COGZF and MDRM have similar daily volatility (0.00).Check MDRM's competition here
COGZF vs LVCE Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, COGZF is priced at $1.55, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas LVCE's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to LVCE's ROE of N/A. Regarding short-term risk, COGZF is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check LVCE's competition here
COGZF vs ACHKF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, COGZF is priced at $1.55, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, COGZF's ROE is +0.27%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, COGZF and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
COGZF vs NHIQ Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, COGZF is priced at $1.55, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, COGZF is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check NHIQ's competition here
COGZF vs EWLL Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, COGZF is priced at $1.55, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EWLL's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, COGZF is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check EWLL's competition here
COGZF vs ALDNF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, COGZF is priced at $1.55, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ALDNF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, COGZF and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
COGZF vs TSTTF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, COGZF is priced at $1.55, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, COGZF's ROE is +0.27%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, COGZF is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check TSTTF's competition here
COGZF vs EMYSF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, COGZF is priced at $1.55, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas EMYSF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, COGZF is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check EMYSF's competition here
COGZF vs RVRC Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, RVRC has a market cap of 117.5K. Regarding current trading prices, COGZF is priced at $1.55, while RVRC trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas RVRC's P/E ratio is -0.32. In terms of profitability, COGZF's ROE is +0.27%, compared to RVRC's ROE of +0.02%. Regarding short-term risk, COGZF is less volatile compared to RVRC. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check RVRC's competition here
COGZF vs NEWUF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, COGZF is priced at $1.55, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, COGZF's ROE is +0.27%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, COGZF and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
COGZF vs PASO Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, COGZF is priced at $1.55, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PASO's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to PASO's ROE of +6.20%. Regarding short-term risk, COGZF and PASO have similar daily volatility (0.00).Check PASO's competition here
COGZF vs LFCOF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, LFCOF has a market cap of 71.6K. Regarding current trading prices, COGZF is priced at $1.55, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, COGZF's ROE is +0.27%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, COGZF is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check LFCOF's competition here
COGZF vs REFG Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, COGZF is priced at $1.55, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas REFG's P/E ratio is -0.01. In terms of profitability, COGZF's ROE is +0.27%, compared to REFG's ROE of +0.01%. Regarding short-term risk, COGZF and REFG have similar daily volatility (0.00).Check REFG's competition here
COGZF vs SOFE Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, COGZF is priced at $1.55, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SOFE's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, COGZF is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check SOFE's competition here
COGZF vs HDVY Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, COGZF is priced at $1.55, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HDVY's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, COGZF is less volatile compared to HDVY. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check HDVY's competition here
COGZF vs MDXL Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MDXL has a market cap of 41.1K. Regarding current trading prices, COGZF is priced at $1.55, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MDXL's P/E ratio is -0.01. In terms of profitability, COGZF's ROE is +0.27%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, COGZF is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check MDXL's competition here
COGZF vs IGRW Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, COGZF is priced at $1.55, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas IGRW's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, COGZF is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check IGRW's competition here
COGZF vs WMGR Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, COGZF is priced at $1.55, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas WMGR's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, COGZF and WMGR have similar daily volatility (0.00).Check WMGR's competition here
COGZF vs SSYNF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, COGZF is priced at $1.55, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to SSYNF's ROE of N/A. Regarding short-term risk, COGZF and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
COGZF vs TTBLF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, COGZF is priced at $1.55, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, COGZF is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check TTBLF's competition here
COGZF vs NMXS Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, NMXS has a market cap of 18.8K. Regarding current trading prices, COGZF is priced at $1.55, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas NMXS's P/E ratio is -0.05. In terms of profitability, COGZF's ROE is +0.27%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, COGZF is less volatile compared to NMXS. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check NMXS's competition here
COGZF vs NHEL Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, COGZF is priced at $1.55, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas NHEL's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, COGZF and NHEL have similar daily volatility (0.00).Check NHEL's competition here
COGZF vs FDBH Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, COGZF is priced at $1.55, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas FDBH's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, COGZF and FDBH have similar daily volatility (0.00).Check FDBH's competition here
COGZF vs ORHB Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ORHB has a market cap of 13.8K. Regarding current trading prices, COGZF is priced at $1.55, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ORHB's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, COGZF and ORHB have similar daily volatility (0.00).Check ORHB's competition here
COGZF vs BNVIF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, COGZF is priced at $1.55, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas BNVIF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, COGZF is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check BNVIF's competition here
COGZF vs HLTT Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, COGZF is priced at $1.55, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HLTT's P/E ratio is -0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, COGZF and HLTT have similar daily volatility (0.00).Check HLTT's competition here
COGZF vs CGNSF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, COGZF is priced at $1.55, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CGNSF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, COGZF is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CGNSF's competition here
COGZF vs MOSTQ Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, COGZF is priced at $1.55, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, COGZF's ROE is +0.27%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, COGZF and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
COGZF vs ACNV Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, COGZF is priced at $1.55, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ACNV's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, COGZF and ACNV have similar daily volatility (0.00).Check ACNV's competition here
COGZF vs AHGIF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, COGZF is priced at $1.55, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas AHGIF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, COGZF is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check AHGIF's competition here
COGZF vs BBLNF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, COGZF is priced at $1.55, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas BBLNF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, COGZF and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
COGZF vs ETAOF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ETAOF has a market cap of 2K. Regarding current trading prices, COGZF is priced at $1.55, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ETAOF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, COGZF and ETAOF have similar daily volatility (0.00).Check ETAOF's competition here
COGZF vs ICCO Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, COGZF is priced at $1.55, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas ICCO's P/E ratio is -0.01. In terms of profitability, COGZF's ROE is +0.27%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, COGZF is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check ICCO's competition here
COGZF vs HSCHF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, HSCHF has a market cap of 1.3K. Regarding current trading prices, COGZF is priced at $1.55, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas HSCHF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, COGZF and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
COGZF vs PCYS Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, COGZF is priced at $1.55, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas PCYS's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, COGZF is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check PCYS's competition here
COGZF vs CNONF Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, COGZF is priced at $1.55, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas CNONF's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, COGZF is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check CNONF's competition here
COGZF vs OLMM Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, COGZF is priced at $1.55, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas OLMM's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, COGZF is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check OLMM's competition here
COGZF vs LGBI Comparison March 2026
COGZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COGZF stands at 265.9M. In comparison, LGBI has a market cap of 50. Regarding current trading prices, COGZF is priced at $1.55, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COGZF currently has a P/E ratio of 25.83, whereas LGBI's P/E ratio is N/A. In terms of profitability, COGZF's ROE is +0.27%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, COGZF is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for COGZF.Check LGBI's competition here